![[Deutsche Gesellschaft für Chirurgie] Chirurgisches Forum und DGAV Forum 2009 Volume 38 || XPC 939 and XRCC3 polymorphisms as prognostic markers in locally advanced esophageal and gastric adenocarcinoma treated with cisplatin and 5-FU based neoadjuvant chemotherapy]()
[Deutsche Gesellschaft für Chirurgie] Chirurgisches Forum und DGAV Forum 2009 Volume 38 || XPC 939 and XRCC3 polymorphisms as prognostic markers in locally advanced esophageal and gastric adenocarcinoma treated with cisplatin and 5-FU based neoadjuvant chemotherapySchumpelick, V.; Bruch, H. -P.; Schackert, H. K. · 2009